Transfemoral TAVR with a self-expanding valve is a feasible treatment for severe aortic regurgitation following LVAD implantation.
Suggests a feasible, less invasive option for severe aortic regurgitation in LVAD patients;.
Aortic insufficiency following left ventricular assist device implantation (LVAD) has been reported in up to 40% of patients and is associated with a worse prognosis. We describe the case of a successful transfemoral transcatheter aortic valve replacement with a self-expanding bioprosthesis for aortic insufficiency following destination LVAD implantation.
No takes yet. Share an insight, caveat, or question.
Rene et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: